English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

It is important for an infection control team to detect patients with severe infection and promote physicians in prompt adequate therapy. The aim of this study was to identify short-term prognostic factors in patients with fever and elevated serum procalcitonin. A total of 425 patients (investigation group, n = 217 and validation group, n = 208) who had fever of more than 38°C and elevated procalcitonin of more than 2.0 ng/mL were included. Four factors, including Creactive protein ≧ 22.57 mg/dL, serum albumin < 2.8 g/dL, blood urea nitrogen ≧ 32 mg/dL, and red cell distribution width ≧ 15.3, were significant independent prognostic factors for 30-day survival in multivariate analysis of the investigation group. Four variables, which were assigned 1 point each, were used to create a prognostic score (PS). 30-day survival was significantly worse in the elevated PS: 100%, 85%, and 64% in PS: 0, PS: 1/2, and PS: 3/4, respectively (p = 0.0010). The 30-day survival of validation group was well stratified by PS: 90%, 81%, and 52% in PS: 0, PS: 1/2, and PS: 3/4, respectively (p = 0.0001). Among patients with fever and elevated serum procalcitonin, a proposed scoring system may identify patients most likely to benefit from ICT assistance.

Short-term Prognostic Factors of Patients with Fever and Elevated Serum Procalcitonin